These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16473411)

  • 1. Estrogen therapy and thrombotic risk.
    Miller VM; Jayachandran M; Heit JA; Owen WG
    Pharmacol Ther; 2006 Sep; 111(3):792-807. PubMed ID: 16473411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ageing, oestrogen, platelets and thrombotic risk.
    Miller VM; Jayachandran M; Owen WG
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):814-21. PubMed ID: 17600564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy and venous thromboembolism].
    Trillot N; Susen S; Jude B
    Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common risk factors for both arterial and venous thrombosis.
    Lowe GD
    Br J Haematol; 2008 Mar; 140(5):488-95. PubMed ID: 18275426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent administration of sustained-release bezafibrate may counteract the increased thrombotic risk associated with oral estrogen therapy.
    McCarty MF
    Med Hypotheses; 2001 Aug; 57(2):216-20. PubMed ID: 11461176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women.
    Koh KK; Horne MK; Cannon RO
    Thromb Haemost; 1999 Aug; 82(2):626-33. PubMed ID: 10605760
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women.
    Prime DD; Brosnihan KB; Herrington DM
    Minerva Cardioangiol; 2007 Aug; 55(4):477-85. PubMed ID: 17653023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia.
    Gangat N; Wolanskyj AP; Schwager SM; Mesa RA; Tefferi A
    Cancer; 2006 Jun; 106(11):2406-11. PubMed ID: 16628652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.
    Kjaergaard AD; Ellervik C; Tybjaerg-Hansen A; Axelsson CK; Grønholdt ML; Grande P; Jensen GB; Nordestgaard BG
    Circulation; 2007 Feb; 115(7):861-71. PubMed ID: 17309937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings.
    Canonico M; Straczek C; Oger E; Plu-Bureau G; Scarabin PY
    Maturitas; 2006 Jul; 54(4):372-9. PubMed ID: 16730142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
    Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
    Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE; Siegel F
    Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Teede HJ
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.